ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.619,72
0,65%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. PhaseBio Pharmaceuticals Inc (CE) (PHASQ)

  7. PhaseBio Pharmaceuticals Inc (CE) (PHASQ) News

PHASQ

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PHASQ
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202422h32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
16/05/202422h28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
29/11/202322h55Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
15/11/202322h17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
03/10/202313h17Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
27/09/202314h52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
25/08/202318h34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
25/08/202318h31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/06/202322h21Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/05/202322h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202322h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202322h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202322h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
16/05/202322h23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
03/04/202322h06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
24/03/202313h08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
14/02/202323h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
14/02/202321h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
14/02/202320h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
23/12/202214h34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
21/12/202212h10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
02/12/202222h20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
15/11/202222h21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
04/11/202221h44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:PHASQ

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
LHA
Deutsche Lufthansa
COIN
SOLUSD
Solana
NASDAQ
AMZN
Amazon.com
FX
EURGBP
Euro vs Sterling
DBI
TDXP
Tec DAX
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
DBI
SDXP
SDAX
TG
DBK
Deutsche Bank
TG
RHM
Rheinmetall
USOTC
ADDYY
Adidas (QX)
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten